CENTAURUS FINANCIAL, INC. - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 158 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
CENTAURUS FINANCIAL, INC. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2018$3,000–330–0.00%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q2 2018.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders